Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Cash from Operations: 2015-2025

Historic Cash from Operations for Wave Life Sciences (WVE) over the last 11 years, with Sep 2025 value amounting to -$44.7 million.

  • Wave Life Sciences' Cash from Operations rose 3.90% to -$44.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$197.4 million, marking a year-over-year decrease of 40.36%. This contributed to the annual value of -$151.0 million for FY2024, which is 677.24% down from last year.
  • Latest data reveals that Wave Life Sciences reported Cash from Operations of -$44.7 million as of Q3 2025, which was up 2.93% from -$46.0 million recorded in Q2 2025.
  • In the past 5 years, Wave Life Sciences' Cash from Operations ranged from a high of $85.5 million in Q1 2023 and a low of -$63.0 million during Q1 2025.
  • Over the past 3 years, Wave Life Sciences' median Cash from Operations value was -$37.3 million (recorded in 2023), while the average stood at -$29.5 million.
  • In the last 5 years, Wave Life Sciences' Cash from Operations plummeted by 375.47% in 2022 and then surged by 314.49% in 2023.
  • Over the past 5 years, Wave Life Sciences' Cash from Operations (Quarterly) stood at -$7.0 million in 2021, then tumbled by 375.47% to -$33.4 million in 2022, then rose by 0.60% to -$33.2 million in 2023, then slumped by 31.32% to -$43.6 million in 2024, then increased by 3.90% to -$44.7 million in 2025.
  • Its Cash from Operations was -$44.7 million in Q3 2025, compared to -$46.0 million in Q2 2025 and -$63.0 million in Q1 2025.